Avanos Medical Inc (AVNS)

Net profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	-392,100	15,700	7,700	-62,200	-61,800	-55,400	-36,000	43,500	49,800	42,900	-7,900	18,600	5,200	-52,000	2,400	-38,500	-27,200	13,900	-16,900	-21,900
Revenue (ttm)	US$ in thousands	687,800	681,500	682,400	680,100	705,700	749,900	780,700	814,300	820,000	795,900	777,900	761,300	744,600	736,200	737,800	715,100	714,800	719,600	705,300	713,800
Net profit margin		-57.01%	2.30%	1.13%	-9.15%	-8.76%	-7.39%	-4.61%	5.34%	6.07%	5.39%	-1.02%	2.44%	0.70%	-7.06%	0.33%	-5.38%	-3.81%	1.93%	-2.40%	-3.07%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-392,100K ÷ $687,800K
= -57.01%

The net profit margin of Avanos Medical Inc has exhibited significant fluctuations over the periods presented. The company's net profit margin was negative in multiple quarters, indicating that expenses exceeded revenues during those periods.

There was a notable improvement in the net profit margin in September 2020 and December 2022, where the company generated positive net profit margins of 1.93% and 6.07% respectively.

However, the net profit margin deteriorated in the subsequent quarters, with significant declines seen in March 2023, December 2023, and March 2024, where the company reported increasingly negative net profit margins of -8.76%, -9.15%, and -57.01% respectively.

The data reflects volatility in Avanos Medical Inc's profitability, suggesting challenges in managing expenses and generating sufficient revenues to cover costs. The company may need to focus on improving operational efficiency and boosting revenues to enhance its overall profitability in the future.